Recovery Oriented Cognitive Therapy for Suicide Risk
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to develop and test a new therapy called Continuous Identity Cognitive Therapy (CI-CT) to support Veterans who have experienced suicidal thoughts or actions. The goal is to help these Veterans build a positive sense of self and future through structured group sessions. Participants will be divided into groups, with some receiving the new CI-CT therapy and others participating in general health education sessions for comparison. Veterans who have attempted suicide or had a serious plan in the past year and are currently receiving mental health services in NYC might be a good fit for this trial. As an unphased study, this trial offers Veterans a unique opportunity to contribute to the development of innovative mental health therapies.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Continuous Identity Cognitive Therapy (CI-CT) is practical and well-received by Veterans who have experienced suicidal thoughts. Studies indicate that Veterans find this therapy helpful and are generally open to participating. CI-CT aims to boost hope, reduce depression, and address suicidal thoughts.
Although this therapy is still fairly new, early feedback suggests it is well-tolerated. Veterans report positive experiences, and significant negative effects have not been reported. This therapy includes group sessions that focus on personal growth and planning for the future, which participants seem to appreciate. However, like any new treatment, ongoing research will help confirm its safety and effectiveness over time.12345Why are researchers excited about this trial?
Researchers are excited about Continuous Identity Cognitive Therapy (CI-CT) because it offers a fresh approach to reducing suicide risk by integrating cognitive-behavioral therapy (CBT) and Acceptance and Commitment Therapy (ACT) with unique components. Unlike traditional therapies that often focus on immediate symptom relief, CI-CT emphasizes building a continuous identity and a future-oriented life story, helping individuals connect with their desired future selves. This therapy aims to increase hopefulness, life meaning, and empowerment by constructing a personal narrative and identifying life values, which are new ways of engaging patients compared to standard therapies.
What evidence suggests that this trial's treatments could be effective for Veterans with suicidal symptoms?
Research has shown that Continuous Identity Cognitive Therapy (CI-CT), one of the treatments studied in this trial, may assist Veterans who have experienced a Post-Acute Suicidal Episode (PASE). CI-CT aims to enhance how Veterans perceive their life story and future, potentially increasing feelings of hope and purpose. Early studies suggest that CI-CT is practical and well-received by Veterans, indicating they are likely to participate and benefit from it. By integrating elements of Cognitive Behavioral Therapy (CBT) and Acceptance and Commitment Therapy (ACT), CI-CT helps Veterans connect with their future selves and pursue personal goals. Although further research is necessary, these early findings suggest that CI-CT could be a valuable tool for supporting Veterans' mental health recovery. Another group in this trial will receive General Health Education, serving as an active control condition.13467
Who Is on the Research Team?
Yosef A Sokol, PhD
Principal Investigator
James J. Peters Veterans Affairs Medical Center
Are You a Good Fit for This Trial?
This trial is for U.S. Military Veterans in the NYC region who've had a suicide attempt or plan within the past year but are currently stable enough to join group therapy. They must be involved in mental health services and medically stable, with no acute suicidal symptoms or imminent risk behaviors.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment Development
Three one-arm treatment development trials of CI-CT to test and improve the therapy protocol
Pilot RCT
Pilot RCT to assess the acceptability and feasibility of CI-CT for PASE Veterans
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Continuous Identity Cognitive Therapy (CI-CT)
- General Health Education
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor